Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
|
| gptkbp:acquisition |
gptkb:Alexion_Pharmaceuticals
|
| gptkbp:ceo |
gptkb:Dr._Milind_Deshpande
|
| gptkbp:clinical_trial |
Phase 2 trials for HCV
|
| gptkbp:focus |
HCV (Hepatitis C Virus) therapeutics
|
| gptkbp:founded |
gptkb:1998
|
| gptkbp:founder |
gptkb:Dr._Michael_A._Sofia
|
| gptkbp:headquarters |
gptkb:New_Haven,_Connecticut
|
| https://www.w3.org/2000/01/rdf-schema#label |
Achillion Pharmaceuticals
|
| gptkbp:research_areas |
infectious diseases
|
| gptkbp:stock_exchange |
gptkb:NASDAQ
|
| gptkbp:bfsParent |
gptkb:Alexion_Pharmaceuticals
|
| gptkbp:bfsLayer |
5
|